- Home
- TARS vs SLVM Comparison
TARS vs SLVM Comparison
Compare TARS & SLVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARS
- SLVM
- Stock Information
- Founded
- TARS 2016
- SLVM 1898
- Country
- TARS United States
- SLVM United States
- Employees
- TARS N/A
- SLVM N/A
- Industry
- TARS Medicinal Chemicals and Botanical Products
- SLVM Paper
- Sector
- TARS Health Care
- SLVM Basic Materials
- Exchange
- TARS Nasdaq
- SLVM Nasdaq
- Market Cap
- TARS 1.7B
- SLVM 1.8B
- IPO Year
- TARS 2020
- SLVM N/A
- Fundamental
- Price
- TARS $49.36
- SLVM $43.35
- Analyst Decision
- TARS Strong Buy
- SLVM Hold
- Analyst Count
- TARS 7
- SLVM 3
- Target Price
- TARS $67.14
- SLVM $75.00
- AVG Volume (30 Days)
- TARS 652.0K
- SLVM 410.6K
- Earning Date
- TARS 11-12-2025
- SLVM 11-11-2025
- Dividend Yield
- TARS N/A
- SLVM 4.16%
- EPS Growth
- TARS N/A
- SLVM N/A
- EPS
- TARS N/A
- SLVM 5.23
- Revenue
- TARS $295,521,000.00
- SLVM $3,550,000,000.00
- Revenue This Year
- TARS $33,170.29
- SLVM N/A
- Revenue Next Year
- TARS N/A
- SLVM $1.88
- P/E Ratio
- TARS N/A
- SLVM $8.28
- Revenue Growth
- TARS 254.45
- SLVM N/A
- 52 Week Low
- TARS $30.23
- SLVM $37.52
- 52 Week High
- TARS $59.76
- SLVM $98.02
- Technical
- Relative Strength Index (RSI)
- TARS 36.86
- SLVM 42.93
- Support Level
- TARS $55.45
- SLVM $43.12
- Resistance Level
- TARS $59.76
- SLVM $45.79
- Average True Range (ATR)
- TARS 2.01
- SLVM 1.10
- MACD
- TARS -1.34
- SLVM 0.04
- Stochastic Oscillator
- TARS 8.77
- SLVM 18.50
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About SLVM Sylvamo Corporation
Sylvamo Corp is an uncoated papers company with a broad portfolio of top-tier brands and low-cost, large-scale paper mills, it produces uncoated freesheet (UFS) for paper products such as cut size and offset paper, as well as market pulp. The company offers Copy and Printer papers, Commercial Printing papers, Converting papers and Specialty papers. It operates in three geographical segments: Europe, Latin America, and North America. Key revenue is generated from North America.